A Phase 1, Randomized, Double-Blinded, Placebo-Controlled, Parallel Group Study to Evaluate the Effect of Bepirovirsen on Cardiac Conduction as Assessed by 12-lead Electrocardiogram in Healthy Volunteers
Latest Information Update: 24 Jun 2025
At a glance
- Drugs Bepirovirsen (Primary)
- Indications Hepatitis B
- Focus Adverse reactions
- Sponsors GSK
Most Recent Events
- 17 Jun 2025 Status changed from recruiting to completed.
- 15 Apr 2025 Planned End Date changed from 16 Apr 2025 to 23 Apr 2025.
- 15 Apr 2025 Planned primary completion date changed from 16 Apr 2025 to 23 Apr 2025.